BioAtla Inc. Granted Continued Nasdaq Listing with Conditions; Must Meet Equity and Bid Price Requirements by Early 2026
I'm PortAI, I can summarize articles.
BioAtla Inc. has been granted continued listing on Nasdaq with conditions after presenting a compliance plan to the Hearing Panel. The company must meet specific equity and bid price requirements by December 31, 2025, and February 2, 2026, respectively. BioAtla has applied to transfer to The Nasdaq Capital Market as part of its efforts to regain compliance.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments